pyridostigmine bromide has been researched along with Hypoglycemia in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carballo, A; Casanueva, FF; Dieguez, C; PeƱalva, A; Pombo, M | 1 |
Barkan, AL; DeMott-Friberg, R; Jaffe, CA | 1 |
Aimaretti, G; Bartolotta, E; Bellone, J; Bellone, S; Camanni, F; Cappa, M; Dammacco, F; Ghigo, E; Loche, S | 1 |
Falhof, J; Hoeck, HC; Jakobsen, PE; Laurberg, P; Vestergaard, P | 1 |
Frohman, LA; Kelijman, M | 1 |
Casanueva, FF; Cordido, F; Dieguez, C | 1 |
1 trial(s) available for pyridostigmine bromide and Hypoglycemia
Article | Year |
---|---|
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
Topics: Adrenergic alpha-Agonists; Arginine; Cholinesterase Inhibitors; Clonidine; Female; Growth Hormone; Growth Hormone-Releasing Hormone; Hormone Antagonists; Humans; Hypoglycemia; Levodopa; Male; Pyridostigmine Bromide; Secretory Rate; Somatostatin | 1996 |
5 other study(ies) available for pyridostigmine bromide and Hypoglycemia
Article | Year |
---|---|
Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Topics: Adult; Atropine; Growth Hormone; Growth Hormone-Releasing Hormone; Hormones; Humans; Hypoglycemia; Insulin; Kinetics; Male; Oligopeptides; Pyridostigmine Bromide; Reference Values; Time Factors | 1993 |
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Topics: Adolescent; Arginine; Child; Child, Preschool; Clonidine; Exercise; Female; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Insulin; Insulin-Like Growth Factor I; Levodopa; Male; Pyridostigmine Bromide; Reproducibility of Results | 1996 |
Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
Topics: Adult; Clonidine; Female; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemia; Hypothalamic Diseases; Insulin; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Diseases; Pyridostigmine Bromide; Reproducibility of Results | 2000 |
The role of the cholinergic pathway in growth hormone feedback.
Topics: Administration, Oral; Adolescent; Adult; Arginine; Cholinergic Fibers; Feedback; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Male; Pituitary Gland; Pyridostigmine Bromide; Thyrotropin; Thyrotropin-Releasing Hormone | 1991 |
Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Topics: Adolescent; Adult; Arginine; Child; Cholinergic Fibers; Clonidine; Drug Interactions; Female; Growth Hormone; Humans; Hypoglycemia; Hypothalamus; Insulin; Middle Aged; Obesity; Prolactin; Pyridostigmine Bromide; Synaptic Transmission; Thyrotropin; Thyrotropin-Releasing Hormone | 1990 |